- June 18, 2021
- Posted by: Stratford Team
- Category: Business
No Comments
ARLINGTON, Va., June 18, 2021 /PRNewswire/ — Science and Medicine Group, the company behind Instrument Business Outlook, Kalorama Information, SDi and other publications, announces the publication of Cell and Gene Therapy Business Outlook.
“With thousands of potential therapies on the market, everyone knows there is potential,” said Bruce Carlson, Senior VP of Publications for Science and Medicine Group. “The question that will continue to be asked is – how much money are companies making selling cell and gene therapy products, and what will be the future potential?”
This new twice-monthly publication dedicated to cell and gene therapy, Cell and Gene Therapy Business Outlook offers the following:
- Executive News Summaries – What is Happening in cell and gene therapy (CGT) Markets and Why It Matters
- Deals Between CGT Companies
- Market Sizing and Forecasting of CGT Markets
- Important Science That Will Shape Tomorrow’s Business
- Company Profiling…
